Zusammenfassung
Der Begriff „asymptomatisches WPW“ wird als Synonym für eine ventrikuläre Präexzitation vom WPW (Wolff-Parkinson-White) Typ aufgrund einer akzessorischen Leitungsbahn verwendet, die sich im Elektrokardiogramm (EKG) im Sinusrhythmus durch eine kurze PQ-Zeit mit Deltawelle manifestiert, ohne dass es bei den Betroffenen zum Auftreten von paroxysmalen Tachykardien kommt. Häufig wird das asymptomatische WPW als Zufallsbefund bei jüngeren Personen ohne sonstige kardiale Auffälligkeiten diagnostiziert. Es besteht ein geringes Risiko des plötzlichen Herztods durch eine schnelle Überleitung auf die Herzkammern über die akzessorische Bahn bei Vorhofflimmern. In diesem Artikel werden verschiedene Aspekte zur nichtinvasiven und invasiven Risikostratifizierung, zur Therapie durch Katheterablation und zur individuellen Risk-Benefit-Diskussion bei asymptomatischem WPW beleuchtet.
Abstract
The term “asymptomatic WPW” (Wolff–Parkinson–White) is often used as a synonym for ventricular pre-excitation of the WPW type due to an accessory pathway characterized by a short PR interval and a delta wave on the electrocardiogram (ECG) without the clinical occurrence of paroxysmal tachycardia. Asymptomatic WPW is often diagnosed in young and otherwise healthy people. There is a small associated risk of sudden cardiac death due to rapid antegrade conduction over the accessory pathway during atrial fibrillation. This paper highlights aspects of noninvasive and invasive risk stratification, therapy by catheter ablation, and the ongoing risk–benefit discussion in asymptomatic WPW.
Literatur
Wolff L, Parkinson J, White PD (2006) Bundle-branch block with short P‑R interval in healthy young people prone to paroxysmal tachycardia. 1930. Ann Noninvasive Electrocardiol 11(4):340–353
Holzmann M (1932) Über Elektrokardiogramme mit verkürzter Vorhofkammer – Distanz und positive P‑Zacken. Z Klin Med 121:404
Cohen MI et al (2012) PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the pediatric and congenital electrophysiology society (PACES) and the heart rhythm society (HRS). Endorsed by the governing bodies of PACES, HRS, the American college of cardiology foundation (ACCF), the American heart association (AHA), the American academy of pediatrics (AAP), and the Canadian heart rhythm society (CHRS). Heart Rhythm 9(6):1006–1024
Emmel M, Balaji S, Sreeram N (2004) Ventricular preexcitation associated with dilated cardiomyopathy: a causal relationship? Cardiol Young 14(6):594–599
Montoya PT et al (1991) Ventricular fibrillation in the Wolff-Parkinson-White syndrome. Eur Heart J 12(2):144–150
Timmermans C et al (1995) Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol 76(7):492–494
Munger TM et al (1993) A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953–1989. Circulation 87(3):866–873
Santinelli V et al (2009) The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children. J Am Coll Cardiol 53(3):275–280
Dreifus LS et al (1971) Ventricular fibrillation. A possible mechanism of sudden death in patients and Wolff-Parkinson-White syndrome. Circulation 43(4):520–527
Fukatani M et al (1990) Prediction of a fatal atrial fibrillation in patients with asymptomatic Wolff-Parkinson-White pattern. Jpn Circ J 54(10):1331–1339
Pietersen AH, Andersen ED, Sandøe E (1992) Atrial fibrillation in the Wolff-Parkinson-White syndrome. Am J Cardiol 70(5):38a–43a
Rao AL et al (2014) Evaluation and management of Wolff-Parkinson-White in athletes. Sports Health 6(4):326–332
Arnar DO et al (2019) Management of asymptomatic arrhythmias: a European heart rhythm association (EHRA) consensus document, endorsed by the heart failure association (HFA), heart rhythm society (HRS), asia pacific heart rhythm society (APHRS), cardiac arrhythmia society of southern africa (CASSA), and latin america heart rhythm society (LAHRS). Europace 21(6):844–845
Pappone C et al (2003) Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study. J Am Coll Cardiol 41(2):239–244
Etheridge SP et al (2018) Life-threatening event risk in children with Wolff-Parkinson-White syndrome: a multicenter international study. JACC Clin Electrophysiol 4(4):433–444
Page RL et al (2016) 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol 67(13):e27–e115
Zipes DP et al (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 9: arrhythmias and conduction defects: a scientific statement from the American heart association and American college of cardiology. J Am Coll Cardiol 66(21):2412–2423
Brembilla-Perrot B, Girerd N, Sellal JM (2018) Unresolved questions associated with the management of ventricular preexcitation syndrome. Pacing Clin Electrophysiol 41(7):839–844
Pelliccia A et al (2005) Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the study group of sports cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial diseases of the European society of cardiology. Eur Heart J 26(14):1422–1445
Vidaillet HJ Jr. et al (1987) Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome). N Engl J Med 317(2):65–69
Daubert C et al (1988) Failure of the exercise test to predict the anterograde refractory period of the accessory pathway in Wolff Parkinson White syndrome. Pacing Clin Electrophysiol 11(8):1130–1138
Czosek RJ et al (2011) Noninvasive risk stratification techniques in pediatric patients with ventricular preexcitation. Pacing Clin Electrophysiol 34(5):555–562
Dalili M et al (2014) Exercise testing in children with Wolff-Parkinson-White syndrome: what is its value? Pediatr Cardiol 35(7):1142–1146
Escudero CA et al (2020) Loss of ventricular preexcitation during noninvasive testing does not exclude high-risk accessory pathways: a multicenter study of WPW in children. Heart Rhythm 17(10):1729–1737
Brugada J et al (2020) 2019 ESC guidelines for the management of patients with supraventricular tachycardia. The task force for the management of patients with supraventricular tachycardia of the European society of cardiology (ESC). Eur Heart J 41(5):655–720
Klein GJ, Gulamhusein SS (1983) Intermittent preexcitation in the Wolff-Parkinson-White syndrome. Am J Cardiol 52(3):292–296
Telishevska M et al (2019) Catheter ablation in ASymptomatic PEDiatric patients with ventricular preexcitation: results from the multicenter “CASPED” study. Clin Res Cardiol 108(6):683–690
Obeyesekere MN, Klein GJ (2017) Application of the 2015 ACC/AHA/HRS guidelines for risk stratification for sudden death in adult patients with asymptomatic pre-excitation. J Cardiovasc Electrophysiol 28(7):841–848
Garg J et al (2017) Catheter ablation of accessory pathway: 14-year trends in utilization and complications in adults in the United States. Int J Cardiol 248:196–200
Mao J et al (2015) Catheter ablation of accessory pathways near the coronary sinus: value of defining coronary arterial anatomy. Heart Rhythm 12(3):508–514
Pappone C et al (2003) A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. N Engl J Med 349(19):1803–1811
Wellens HJ (2005) Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram. Circulation 112(14):2201–2207 (discussion 2216)
Pappone C et al (2014) Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients. Circulation 130(10):811–819
Schmitt C, Deisenhofer I, Zrenner B (2006) Catheter ablation of cardiac arrhythmias. A practical approach. Steinkopff Verlag, Darmstadt
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
G. Hessling: speaker and travel fee Abbott, M. Telishevska: speaker and travel fee Abbott, S. Lengauer: speaker and travel fee Abbott, I. Deisenhofer: speaker and travel fee Abbott, Speaker and travel fee Biosense Webster, speaker and travel fee Boston Scientific.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Hessling, G., Telishevska, M., Lengauer, S. et al. „Asymptomatisches WPW“. Herzschr Elektrophys 34, 114–121 (2023). https://doi.org/10.1007/s00399-023-00930-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00399-023-00930-x
Schlüsselwörter
- Ventrikuläre Präexzitation, asymptomatisch
- WPW Syndrom
- Ventrikuläre Präexzitation
- Plötzlicher Herztod
- Risikostratifizierung
- Katheterablation